CDX2 is mutated in a colorectal cancer with normal APC/β-catenin signaling
Luís Teixeira da Costa(Johns Hopkins University), Kenneth W. Kinzler(Johns Hopkins University), Andrew B. Sparks(Howard Hughes Medical Institute), Tong‐Chuan He(Northwestern University), Bert Vogelstein(Johns Hopkins University), Patrice J. Morin(National Institutes of Health), Jian Yu(University of Southern California), Steve Laken, Kornélia Polyák(Dana-Farber Cancer Institute)
Cited by 122
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k